Prostate cancer is the second most common cancer in men with almost 200,000 new cases being diagnosed each year. Today increasing numbers of men and their families play a more active role in their treatment and the results can be seen in the increase of men who survive prostate cancer. Yet each year over 27,000 men die from prostate cancer. This makes prostate cancer the second leading cause of cancer death in men behind lung cancer. The range of controversial therapies and treatments for prostate cancer is greater than that of any other cancer affecting men. This makes it difficult for men and their families to determine what are the best options available. Rarely do doctors agree on which treatment a patient should receive or when they should receive it.
